— Know what they know.
Not Investment Advice

THRD NASDAQ

Third Harmonic Bio, Inc.
1W: +0.0% 1M: -1.3% 3M: +4.3% 1Y: -50.5%
$5.38
Last traded 2025-08-12 — delisted
NASDAQ · Healthcare · Biotechnology · $242.8M mcap · 22M float · 1.18% daily turnover · Short 69% of daily vol

Cash Flow Trends

Operating Cash Flow
-$35M -68.9% ▼
Capital Expenditures
$10K +94.1% ▲
Free Cash Flow
-$35M -67.6% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$16M +180.8% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$13M-$30M-$35M-$31M-$45M
Depreciation & Amort.$0$0$1K$35K$49K
Stock-Based Comp.$195K$510K$5M$10M$11M
Change in Working Capital$2M$3M-$5M$223K-$893K
Other Non-Cash Items$2M$11M$37K$564K$724K
Operating Cash Flow-$9M-$16M-$35M-$20M-$35M
— Investing Activities —
Capital Expenditures$0$0-$36K-$169K-$10K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0$0
Investing Cash Flow$0$0-$36K-$169K-$10K
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0-$2M$0$2M
Financing Cash Flow$11M$136M$196M$799K$51M
Net Change in Cash$2M$120M$161M-$20M$16M
Cash End of Period$8M$128M$289M$270M$286M
Free Cash Flow-$9M-$16M-$35M-$21M-$35M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms